Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F5QZJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,815
Award facts
- Contract value 100% obligated
- $42,815.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42.8K delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units), with completion expected by January 16, 2026. This non-competitive delivery order represents a firm fixed-price purchase of a brand-name respiratory medication used to treat chronic obstructive pulmonary disease. The award stems from AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial $1B indefinite delivery contract with DLA Troop Support Medical extending through December 2031, serving as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's Medical Supply Chain. The company demonstrates significant capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, competing on a full and open basis for federal contracts. This delivery order exemplifies the routine pharmaceutical supply operations under the larger indefinite delivery contract, supporting the Defense Health Agency and other government healthcare systems with essential medications and medical commodities.
Quick answers
Who was awarded contract SPE2DR26F5QZJ?
SPE2DR26F5QZJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F5QZJ worth?
The government has obligated $42,815 on SPE2DR26F5QZJ.
Is contract SPE2DR26F5QZJ an order under another contract?
Yes. SPE2DR26F5QZJ is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QZJ competed?
The extent of competition for SPE2DR26F5QZJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award